DiogenX
FranceWho owns DiogenX?
DiogenX is a French Biotech company, currently owned by Omnes Capital since 2023 and 4 other investors.
Hand-verified · updated 2026-09-30
Open JSON · CC-BY
Key facts
- ·Co-held by Boehringer Ingelheim Venture Fund, AdBio Partners, Omnes Capital, Sunstone Life Science Ventures and Aloe Private Equity since 2020.
- ·5 distinct PE sponsors across ownership cycles.
Ownership history
5 ownership periods · co-invest detected
More from Sorbonne Venture
Other portfolio companies in the same fund.
More PE-backed in Biotech
Comparable biotech deals from other GPs.
USQuestions
Who owns DiogenX?
DiogenX is currently owned by Omnes Capital, Sunstone Life Science Ventures and 3 others, through Sorbonne Venture, since 2023.
When did Omnes Capital and 4 others acquire DiogenX?
Omnes Capital and 4 others acquired DiogenX in 2023.
Who has owned DiogenX over time?
DiogenX has been through 5 private-equity ownership periods: Boehringer Ingelheim Venture Fund · via Boehringer Ingelheim Venture Fund · since 2020; AdBio Partners · via AFB Fund II · since 2020; Omnes Capital · via Omnes Real Tech 1 · since 2023; Sunstone Life Science Ventures · via Sunstone Life Science Ventures V · since 2023; Aloe Private Equity · via Sorbonne Venture.